Top

Published in:

01-09-2016

Novel Method for Recruiting Representative At-Risk Individuals into Cancer Prevention Trials: Online Health Risk Assessment in Employee Wellness Programs

Authors: Siu-kuen Azor Hui, Suzanne M. Miller, Leah Hazuda, Kimberly Engelman, Edward F. Ellerbeck

Published in: Journal of Cancer Education | Issue 3/2016

Abstract

Participation in cancer prevention trials (CPT) is lower than 3 % among high-risk healthy individuals, and racial/ethnic minorities are the most under-represented. Novel recruitment strategies are therefore needed. Online health risk assessment (HRA) serves as a gateway component of nearly all employee wellness programs (EWPs) and may be a missed opportunity. This study aimed to explore employees’ interest, willingness, motivators, and barriers of releasing their HRA responses to an external secure research database for recruitment purpose. We used qualitative research methods (focus group and individual interviews) to examine employees’ interest and willingness in releasing their online HRA responses to an external, secure database to register as potential CPT participants. Fifteen structured interviews (40 % of study participants were of racial/ethnic minority) were conducted, and responses reached saturation after four interviews. All employees showed interest and willingness to release their online HRA responses to register as a potential CPT participant. Content analyses revealed that 91 % of participants were motivated to do so, and the major motivators were to (1) obtain help in finding personally relevant prevention trials, (2) help people they know who are affected by cancer, and/or (3) increase knowledge about CPT. A subset of participants (45 %) expressed barriers of releasing their HRA responses due to concerns about credibility and security of the external database. Online HRA may be a feasible but underutilized recruitment method for cancer prevention trials. EWP-sponsored HRA shows promise for the development of a large, centralized registry of racially/ethnically representative CPT potential participants.

National Cancer Institute (2014) Cancer clinical trials fact sheet 2013. Available from: http://www.cancer.gov/cancertopics/factsheet/clinicaltrials/clinical-trials

Colon-Otero G, Smallridge RC, Solberg LA Jr et al (2008) Disparities in participation in cancer clinical trials in the United States: a symptom of a healthcare system in crisis. Cancer 112(3):447–454

Murthy VH, Krumholz HM, Gross CP (2004) Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA 291(22):2720–2726CrossRefPubMed

Hall MJ, Egleston B, Miller SM et al (2010) Barriers to participation in cancer prevention clinical trials. Acta Oncol 49(6):757–766CrossRefPubMedPubMedCentral

Haynes MA, Smedley BD, Institute of Medicine (U.S.), Committee on Cancer Research among Minorities and the Medically Underserved (1999) The unequal burden of cancer: an assessment of NIH research and programs for ethnic minorities and the medically underserved. National Academy Press, Washington, D.C, xi, 338 p

Millon-Underwood S, Sanders E, Davis M (1993) Determinants of participation in state-of-the-art cancer prevention, early detection/screening, and treatment trials among African-Americans. Cancer Nurs 16(1):25–33CrossRefPubMed

Grann VR, Jacobson JS, Troxel AB et al (2005) Barriers to minority participation in breast carcinoma prevention trials. Cancer 104(2):374–379CrossRefPubMed

Woods MN, Harris KJ, Mayo MS, et al (2002) Participation of African Americans in a smoking cessation trial: a quantitative and qualitative study. J Natl Med Assoc 94(7):609–618PubMedPubMedCentral

Larkey LK, Ogden SL, Tenorio S et al (2008) Latino recruitment to cancer prevention/screening trials in the Southwest: setting a research agenda. Appl Nurs Res 21(1):30–39CrossRefPubMed

10.

Moinpour CM, Atkinson JO, Thomas SM et al (2000) Minority recruitment in the prostate cancer prevention trial. Ann Epidemiol 10(8 Suppl):S85–S91CrossRefPubMed

11.

Gross CP, Filardo G, Mayne ST et al (2005) The impact of socioeconomic status and race on trial participation for older women with breast cancer. Cancer 103(3):483–491CrossRefPubMed

12.

Ford ME, Siminoff LA, Pickelsimer E et al (2013) Unequal burden of disease, unequal participation in clinical trials: solutions from African American and Latino community members. Health Soc Work 38(1):29–38CrossRefPubMedPubMedCentral

13.

American Cancer Society (2014) Cancer facts and figures 2014. Atlanta

14.

World Cancer Research Fund (2014) Our cancer prevention recommendations. Available from: http://www.wcrf.org/int/research-we-fund/our-cancer-prevention-recommendations

15.

Ford JG, Howerton MW, Lai GY et al (2008) Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer 112(2):228–242CrossRefPubMed

16.

Calderon JL, Baker RS, Fabrega H et al (2006) An ethno-medical perspective on research participation: a qualitative pilot study. Med Gen Med 8(2):23

17.

Byrne MM, Tannenbaum SL, Glück S et al (2014) Participation in cancer clinical trials why are patients not participating? Med Decis Mak 34(1):116–126CrossRef

18.

Sheppard VB, Cox LS, Kanamori MJ et al (2005) Brief report: if you build it, they will come—methods for recruiting Latinos into cancer research. J Gen Intern Med 20:444–447CrossRefPubMedPubMedCentral

19.

Corbie-Smith G, Thomas SB, Williams MV et al (1999) Attitudes and beliefs of African Americans toward participation in medical research. J Gen Intern Med 14(9):537–546

20.

Robinson JM, Trochim WM (2007) An examination of community members’, researchers’ and health professionals’ perceptions of barriers to minority participation in medical research: an application of concept mapping. Ethn Health 12(5):521–539CrossRefPubMed

21.

Brewster WR, Anton-Culver H, Ziogas A et al (2002) Recruitment strategies for cervical cancer prevention study. Gynecol Oncol 85(2):250–254CrossRefPubMed

22.

Schoenman JA, Chockley N (2011) Building a stronger evidence base for employee wellness programs. National Institute for Health Care Management, Washington, DC

23.

U.S. Bureau of Labor Statistics (2014) Employment status of the civilian noninstitutional population by age, sex, and race 2013

24.

U.S. Bureau of Labor Statistics (2013) Employment status of the Hispanic or Latino population by age and sex

25.

Mattke S, Schnyer C, Van Busum KR (2012) A review of the U S workplace wellness market. Santa Monica

26.

Tu HT, Mayrell RC (2010) Employer wellness initiatives grow, but effectiveness varies widely. Cent Stud Health Syst Change Res Brief 1(1):1–13

27.

Glaser B, Strauss A (1967) The discovery of grounded theory: strategies for qualitative research. Aldine, Chicago

28.

Boyd AD, Hosner C, Hunscher DA et al (2007) An ‘Honest Broker’ mechanism to maintain privacy for patient care and academic medical research. Int J Med Inform 76(5–6):407–411CrossRefPubMed

29.

Boyd AD, Saxman PR, Hunscher DA et al (2009) The University of Michigan Honest Broker: a web-based service for clinical and translational research and practice. J Am Med Inform Assoc 16(6):784–791CrossRefPubMedPubMedCentral

30.

Institute of Medicine (2012) Public engagement and clinical trials: new models and disruptive technologies: workshop summary. In: Weisfeld V, English RA, and Claiborne A.B (eds.) Washington (DC), The National Academies Press

31.

Institute of Medicine (2011) Implementing a national cancer clinical trials system for the 21st century: workshop summary. In: Mack A, and Nass S.J (ed.) Washington, DC, The National Academies Press 100

32.

Institute of Medicine (2010) A National Cancer Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program. The National Academies Press, Washington, DC, p 316

33.

Institute of Medicine (2010) Transforming clinical research in the United States: challenges and opportunities: workshop summary. The National Academies Press, Washington, DC, p 150

34.

Porterfield D, Hinnant L, Kane H et al (2010) Linkages between clinical practices and community organizations for prevention. RTI International: Research Triangle Park, NC, pp iii–C-1

Title: Novel Method for Recruiting Representative At-Risk Individuals into Cancer Prevention Trials: Online Health Risk Assessment in Employee Wellness Programs
Authors: Siu-kuen Azor Hui
Suzanne M. Miller
Leah Hazuda
Kimberly Engelman
Edward F. Ellerbeck
Publication date: 01-09-2016
Publisher: Springer US
Published in: Journal of Cancer Education / Issue 3/2016
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI: https://doi.org/10.1007/s13187-015-0927-8

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2016

“Obesity is the New Major Cause of Cancer”: Connections Between Obesity and Cancer on Facebook and Twitter

Meetings of the mind!

“Cancer Survivors” as Voluntary Helpers in Cancer Associations in France. Limits of the Balance between Service Offer and Social Demand

Community-Based Health Education has Positive Influence on the Attitude to Cervical Cancer Screening among Women in Rural Nepal

Sexual Health Concerns Among Cancer Survivors: Testing a Novel Information-Need Measure Among Breast and Prostate Cancer Patients

Information Needs of Cancer Patients and Perception of Impact of the Disease, of Self-Efficacy, and Locus of Control

Keynote webinar | Spotlight on antibody–drug conjugates in cancer